ITGA2B and Dorfman-Chanarin disease: More recently, other results have confirmed the involvement of platelet aggregation in the pathogenesis of DCS, by this time spotlighting a preventive and beneficial effect of abciximab (ABX; Reopro®), an anti-platelet drug of the anti-GPIIb/IIIa type (Lambrechts et al., 2015).